Literature DB >> 28888040

Phenotypic variation of an ALK-positive large-cell neuroendocrine lung carcinoma with carcinoid morphology during treatment with ALK inhibitors.

Delphine Hoton1,2, Yves Humblet3, Louis Libbrecht1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28888040     DOI： 10.1111/his.13388

Source DB:  PubMed          Journal:  Histopathology        ISSN： 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  7 in total

1.  The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma.

Authors:  Minglei Zhuo; Yanfang Guan; Xue Yang; Lingzhi Hong; Yuqi Wang; Zhongwu Li; Runzhe Chen; Hussein A Abbas; Lianpeng Chang; Yuhua Gong; Nan Wu; Jia Zhong; Wenting Chen; Hanxiao Chen; Zhi Dong; Xiang Zhu; Jianjie Li; Yuyan Wang; Tongtong An; Meina Wu; Ziping Wang; Jiayin Wang; Emily B Roarty; Waree Rinsurongkawong; Jeff Lewis; Jack A Roth; Stephen G Swisher; J Jack Lee; John V Heymach; Ignacio I Wistuba; Neda Kalhor; Ling Yang; Xin Yi; P Andrew Futreal; Bonnie S Glisson; Xuefeng Xia; Jianjun Zhang; Jun Zhao
Journal:  Clin Cancer Res       Date:  2019-11-06       Impact factor: 12.531

2.  A Case of ALK-Rearranged Combined Lung Adenocarcinoma and Neuroendocrine Carcinoma with Diffuse Bone Metastasis and Partial Response to Alectinib.

Authors:  Chloe A Lim; Norbert Banyi; Tracy Tucker; Diana N Ionescu; Barbara Melosky
Journal:  Curr Oncol       Date:  2022-02-03       Impact factor: 3.677

3.  ALK-rearrangement neuroendocrine carcinoma of the lung: a comprehensive study of a rare case series and review of literature.

Authors:  Qiang Zheng; Mingjia Zheng; Yan Jin; Xuxia Shen; Ling Shan; Lei Shen; Yihua Sun; Haiquan Chen; Yuan Li
Journal:  Onco Targets Ther       Date:  2018-08-17       Impact factor: 4.147

Review 4.  Molecular Pathology of Well-Differentiated Pulmonary and Thymic Neuroendocrine Tumors: What Do Pathologists Need to Know?

Authors:  Marco Volante; Ozgur Mete; Giuseppe Pelosi; Anja C Roden; Ernst Jan M Speel; Silvia Uccella
Journal:  Endocr Pathol       Date:  2021-02-27       Impact factor: 3.943

Review 5.  Biomarker Landscape in Neuroendocrine Tumors With High-Grade Features: Current Knowledge and Future Perspective.

Authors:  Michele Prisciandaro; Maria Antista; Alessandra Raimondi; Francesca Corti; Federica Morano; Giovanni Centonze; Giovanna Sabella; Alessandro Mangogna; Giovanni Randon; Filippo Pagani; Natalie Prinzi; Monica Niger; Salvatore Corallo; Erica Castiglioni di Caronno; Marco Massafra; Maria Di Bartolomeo; Filippo de Braud; Massimo Milione; Sara Pusceddu
Journal:  Front Oncol       Date:  2022-02-04       Impact factor: 6.244

6.  Case Report: A Pregnant Woman Diagnosed as ALK-Rearrangement Lung Large Cell Neuroendocrine Cancer With Brain Metastasis.

Authors:  Zaixiang Fu; Ganggui Zhu; Liquan Wang; Shen Hu; Lu Cheng; Fuyi Liu
Journal:  Front Oncol       Date:  2022-02-25       Impact factor: 6.244

7.  Metastatic pulmonary carcinoids with EML4-ALK fusion response to ALK inhibitors: two case reports and review of literature.

Authors:  Xi Lei; Shuai Zhu; Dian Ren; Fan Ren; Tong Li; Ning Zhou; Shuo Li; Tao Shi; Lingling Zu; Zuoqing Song; Justyna Chalubinska-Fendler; Marc G Denis; Eric H Bernicker; Vincent Thomas de Montpréville; Richeng Jiang; Song Xu
Journal:  Transl Lung Cancer Res       Date:  2022-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.